Table 2.
Comparison between the detected and last missed endoscopy.
| Detected endoscopy (n = 119) | Last missed endoscopy (n = 119) | P value | |||
|---|---|---|---|---|---|
| Symptom | 0.65 | ||||
| Symptomatic | 12 | (10.1%) | 10 | (8.4%) | |
| Asymptomatic | 107 | (89.9%) | 109 | (91.6%) | |
| Purpose | 0.81 | ||||
| Screening | 43 | (36.1%) | 43 | (36.1%) | |
| Surveillance | 37 | (31.1%) | 33 | (27.7%) | |
| Annual medical checkup | 39 | (33.0%) | 43 | (36.1%) | |
| Endoscopist | <0.05 | ||||
| Experienced | 86 | (72.3%) | 68 | (57.1%) | |
| Trainee | 33 | (27.7%) | 51 | (42.9%) | |
| Endoscope | 0.42 | ||||
| Normal | 73 | (61.3%) | 74 | (62.2%) | |
| Small-diameter | 35 | (29.4%) | 39 | (32.8%) | |
| Magnifying | 11 | (9.2%) | 6 | (5.0%) | |
| Duration (sec) | 519 | [427–618] | 433 | [371–531] | <0.01 |
| Numbers of pictures | 72 | [65-83] | 66 | [58-72] | <0.01 |
| Sedative drug use | 3 | (2.5%) | 4 | (3.4%) | 0.70 |
| L-menthol use | 6 | (5.0%) | 4 | (3.4%) | 0.52 |
| Indigo carmine use | 118 | (99.2%) | 102 | (85.7%) | <0.01 |
| Biopsies | 116 | (97.5%) | 56 | (47.1%) | <0.01 |
Data are presented as median (IQR) or n (%).